About
Łukasiewicz – PORT is a modern research and development center based in Wrocław and part of the Łukasiewicz Research Network. As one of the largest research institutions in Poland, we focus on technological innovation and interdisciplinary scientific research that drives the development of new technologies – particularly in the fields of health, biotechnology, and materials engineering.
Łukasiewicz – PORT comprises three research centers: the Population Diagnostics Center, the Materials Science & Engineering Center, and the Life Sciences and Biotechnology Center.
Across 18 research groups, 159 scientists from Poland and abroad are currently carrying out over 50 research projects with a total value exceeding PLN 270 million.
Cluster 1: Health
HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion HOHORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate changeHORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate changeHORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potentialHORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from FlavivirusesHORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga virusesHORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobialsHORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseasesHORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseasesHORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medicationsHORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseasesHORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicineHORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosisHORIZON-HLTH-2027-03-TOOL-08: Towards Artificial General Intelligence (AGI) for healthcareHORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicalsHORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
Cluster 4: Digital & Industry
HORIZON-CL4-2027-02-DIGITAL-EMERGING-52-two-stage: New approaches for Human/AI collaboration for the workforce of the future (Made in Europe and AI, Data and Robotics partnerships)HORIZON-CL4-2027-01-MATERIALS-PRODUCTION-42: Unlocking the potential of academic intellectual assets for industry, SMEs and startups